BioLegend CD Posters|書籍線上App不用買

シェア記事:

【免費書籍App】BioLegend CD Posters-APP點子

Welcome to the BioLegend CD Poster application! This application provides you with important information about your mouse and human CD molecules. You can also find out all of the latest news and information about BioLegend including discounts and new products.

【免費書籍App】BioLegend CD Posters-APP點子

BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, offered at an outstanding value, manufactured in our state-of-the-art facility in San Diego, CA.

【免費書籍App】BioLegend CD Posters-APP點子

Our product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. All of BioLegend’s reagents are supported by superior customer service and come with a quality guarantee. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including flow cytometry, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays. BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers’ specific needs.

【免費書籍App】BioLegend CD Posters-APP點子

Incorporated in June 2002, BioLegend is located in San Diego, in the midst of one of the nation’s largest and fastest growing biotechnology clusters.

【免費書籍App】BioLegend CD Posters-APP點子

免費玩BioLegend CD Posters APP玩免費

免費玩BioLegend CD Posters App

BioLegend CD Posters APP LOGO

BioLegend CD Posters LOGO-APP點子

BioLegend CD Posters APP QRCode

BioLegend CD Posters QRCode-APP點子
熱門國家系統支援版本費用APP評分上架日期更新日期
美國 (U.S.A)iOS
App Store
1.4
App下載
免費
2012-10-262014-09-19
シェア記事: